Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
O

Odonate Therapeutics Inc
OTC:ODTC

Watchlist Manager
Odonate Therapeutics Inc
OTC:ODTC
Watchlist
Price: 50 000 USD Market Closed
Market Cap: $52.7m
Write Note Create Alert Ask AI

Net Margin

0%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0%
=
$0
/
$0

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
0%
=
$0
/
$0

Peer Comparison

Country Company Market Cap Net
Margin
US
Odonate Therapeutics Inc
OTC:ODTC
52.7m USD
Loading...
US
Eli Lilly and Co
NYSE:LLY
948.8B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
563B USD
Loading...
CH
Roche Holding AG
SIX:ROG
286.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
213.6B GBP
Loading...
US
Merck & Co Inc
NYSE:MRK
288.1B USD
Loading...
CH
Novartis AG
SIX:NOVN
224.1B CHF
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
146.4B USD
Loading...
FR
Sanofi SA
PAR:SAN
98.2B EUR
Loading...

Market Distribution

Not Available
No Country distribution data available for this multiple

Other Profitability Ratios

Odonate Therapeutics Inc
Glance View

Market Cap
52.7m USD
Industry
Pharmaceuticals

Odonate Therapeutics, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improves and extends the lives of patients with cancer. The company is headquartered in New York City, New York and currently employs 137 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in the development of therapeutics to improve and extend the lives of patients with cancer. The company is focused on the development of tesetaxel, a novel chemotherapy agent. The company has completed Phase-II studies in patients with metastatic breast cancer (MBC). The firm's tesetaxel can be administered orally with a low pill burden and dosing regimen. Taxanes destroy cancer cells by preventing them from entering mitosis and thereby leading to apoptosis (cell death).

ODTC Intrinsic Value
Not Available
O
What is Intrinsic Value?

See Also

Summary
ODTC intrinsic value, competitors valuation, and company profile.
DCF Valuation
ODTC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ODTC stock valuation using valuation multiples.
Wall Street Estimates
ODTC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ODTC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.